Jason M. Rohde

Statistics

Publications

Citations

2.3K

H-Index

Active since

1998

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

University of California, Irvine

Dana-Farber Cancer Institute

The University of Texas Southwestern Medical Center

Jason M. Rohde is an author at National Center for Advancing Translational Sciences specializing in pharmacology, drug discovery, and enzyme inhibition.

ORCID

Publications per year

1998–2021

Publications

Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors

Anju Singh, Sreedhar Venkannagari, Kyu Hee Oh et al. · ACS Chemical Biology · 2016 · 613 citations

Medicine, Oncology, Pharmacology +16

A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate

Michael E. Pacold, Kyle R. Brimacombe, Sze Ham Chan et al. · Nature Chemical Biology · 2016 · 589 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +14

PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth

Emily Montal, Ruby Dewi, Kavita Bhalla et al. · Molecular Cell · 2015 · 272 citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Total Synthesis of (±)- and (−)-Actinophyllic Acid

Connor L. Martin, Larry E. Overman, Jason M. Rohde · Journal of the American Chemical Society · 2010 · 130 citations

Natural Sciences, Biochemistry, Chemistry +13

Total Synthesis of (±)-Actinophyllic Acid

Connor L. Martin, Larry E. Overman, Jason M. Rohde · Journal of the American Chemical Society · 2008 · 120 citations · Full text

Natural Sciences, Biochemistry, Chemistry +12

1–5 of 19